Clinical Studies & Research at Friendship Hospital for Animals
Currently Enrolling – STEM CELL TREATMENT STUDY FOR CATS WITH CHRONIC KIDNEY DISEASE (View PDF)
TRIAL ELIGIBILITY
We are enrolling cats that meet the following criteria:
- Feline patients diagnosed with chronic kidney disease (CKD), IRIS grade 2 or greater prior to enrollment.
- Cats should not have cancer or other concurrent disease conditions that are not controlled/stable.
- Cats should not have received a stem cell product in the past.
REQUIREMENTS
The stem cell therapy consists of an initial treatment followed by a second treatment 14 days apart.
FULLY FUNDED STUDY BENEFITS
- Your client’s cat will receive specialty veterinary care throughout the study, including physical exams, blood work, and urinalysis at NO OUT-OF-POCKET cost to the pet parent.
- There is a 67% chance that the cats will receive drug. 33% of cats will receive a placebo treatment.
We would be happy to provide you with additional information regarding the study. Please reach out to our Clinical Trials Coordinator, Noa Zeevi at 202-363-7300 or clinicaltrials@friendshiphospital.com
Currently Enrolling – Collagen Study
*We are evaluating a treatment for urinary incontinence that is novel in dogs.
*The product has been used for incontinence in women and is also administered in the joints of dogs and horses to be used to help with joint lameness.
*This is a minimally invasive treatment for urinary incontinence in dogs. Compared to urethral collagen bulking, a procedure performed for decades to manage urinary incontinence, we hope that this product produces a prolonged response.
*Patient benefits: potentially one-time procedure vs. collagen administration that needs to be repeated as needed (typically yearly).
*Clients responsibility: Cover procedure costs only – the bulking agent is administered at no charge.
*Financial benefits: $1,000 savings compared to cost of collagen injection.
*Follow-up: 1 & 3 month phone call or email with update. Recheck as needed.
We would be happy to provide you with additional information regarding the study. Please reach out to our Clinical Trials Coordinator, Noa Zeevi at 202-363-7300 or clinicaltrials@friendshiphospital.com